(MedPage Today) — While JAK and interleukin (IL)-23 inhibitors have rapidly entered routine care for ulcerative colitis (UC), the ideal maintenance doses remain unclear. "The unresolved question is: Which patient actually needs the higher maintenance…
Source: MedPage Today — Headlines
